Rank | Gene Set | Z-score |
---|---|---|
1 | desmosome organization (GO:0002934) | 6.43085243 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.09430517 |
3 | L-phenylalanine catabolic process (GO:0006559) | 6.09430517 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.91366627 |
5 | L-phenylalanine metabolic process (GO:0006558) | 5.91366627 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 5.35354181 |
7 | sulfur amino acid catabolic process (GO:0000098) | 5.31052419 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.28196043 |
9 | intestinal epithelial cell development (GO:0060576) | 5.10893164 |
10 | intestinal cholesterol absorption (GO:0030299) | 5.06713999 |
11 | cysteine metabolic process (GO:0006534) | 4.97818099 |
12 | high-density lipoprotein particle remodeling (GO:0034375) | 4.80456229 |
13 | urea metabolic process (GO:0019627) | 4.78073643 |
14 | urea cycle (GO:0000050) | 4.78073643 |
15 | metanephric mesenchyme development (GO:0072075) | 4.75909344 |
16 | tryptophan catabolic process (GO:0006569) | 4.75863559 |
17 | indole-containing compound catabolic process (GO:0042436) | 4.75863559 |
18 | indolalkylamine catabolic process (GO:0046218) | 4.75863559 |
19 | kynurenine metabolic process (GO:0070189) | 4.67897231 |
20 | homocysteine metabolic process (GO:0050667) | 4.64231009 |
21 | bile acid biosynthetic process (GO:0006699) | 4.59731314 |
22 | tryptophan metabolic process (GO:0006568) | 4.57555636 |
23 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.51613731 |
24 | glyoxylate metabolic process (GO:0046487) | 4.49366065 |
25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.39608685 |
26 | intestinal absorption (GO:0050892) | 4.39328679 |
27 | regulation of triglyceride catabolic process (GO:0010896) | 4.39227136 |
28 | nitrogen cycle metabolic process (GO:0071941) | 4.34467854 |
29 | regulation of water loss via skin (GO:0033561) | 4.33444695 |
30 | reverse cholesterol transport (GO:0043691) | 4.32398059 |
31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.32223357 |
32 | protein carboxylation (GO:0018214) | 4.32223357 |
33 | diterpenoid biosynthetic process (GO:0016102) | 4.32012989 |
34 | multicellular organismal water homeostasis (GO:0050891) | 4.31800937 |
35 | bile acid and bile salt transport (GO:0015721) | 4.26059852 |
36 | bile acid metabolic process (GO:0008206) | 4.23246266 |
37 | phospholipid efflux (GO:0033700) | 4.22055833 |
38 | amino-acid betaine metabolic process (GO:0006577) | 4.17654166 |
39 | lysine catabolic process (GO:0006554) | 4.17001798 |
40 | lysine metabolic process (GO:0006553) | 4.17001798 |
41 | serine family amino acid catabolic process (GO:0009071) | 4.16552611 |
42 | regulation of cholesterol esterification (GO:0010872) | 4.15641229 |
43 | negative regulation of fibrinolysis (GO:0051918) | 4.14281944 |
44 | negative regulation of sterol transport (GO:0032372) | 4.13951986 |
45 | negative regulation of cholesterol transport (GO:0032375) | 4.13951986 |
46 | cellular glucuronidation (GO:0052695) | 4.10115103 |
47 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.07925368 |
48 | kidney mesenchyme development (GO:0072074) | 4.06631301 |
49 | drug catabolic process (GO:0042737) | 4.03623285 |
50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.03503608 |
51 | regulation of fibrinolysis (GO:0051917) | 4.03494466 |
52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.03410532 |
53 | protein-lipid complex remodeling (GO:0034368) | 4.03410532 |
54 | macromolecular complex remodeling (GO:0034367) | 4.03410532 |
55 | triglyceride homeostasis (GO:0070328) | 4.01911367 |
56 | acylglycerol homeostasis (GO:0055090) | 4.01911367 |
57 | complement activation, alternative pathway (GO:0006957) | 4.01119394 |
58 | regulation of protein activation cascade (GO:2000257) | 3.99739331 |
59 | aromatic amino acid family metabolic process (GO:0009072) | 3.94472905 |
60 | flavonoid metabolic process (GO:0009812) | 3.90161914 |
61 | regulation of cholesterol homeostasis (GO:2000188) | 3.89219207 |
62 | transcytosis (GO:0045056) | 3.86643340 |
63 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78447708 |
64 | ethanol oxidation (GO:0006069) | 3.78135631 |
65 | cholesterol efflux (GO:0033344) | 3.77544111 |
66 | regulation of complement activation (GO:0030449) | 3.73352634 |
67 | uronic acid metabolic process (GO:0006063) | 3.73072981 |
68 | glucuronate metabolic process (GO:0019585) | 3.73072981 |
69 | cellular modified amino acid catabolic process (GO:0042219) | 3.71786984 |
70 | establishment of skin barrier (GO:0061436) | 3.70679100 |
71 | negative regulation of kidney development (GO:0090185) | 3.70011058 |
72 | water homeostasis (GO:0030104) | 3.69459915 |
73 | alpha-amino acid catabolic process (GO:1901606) | 3.68757522 |
74 | plasma lipoprotein particle assembly (GO:0034377) | 3.67330254 |
75 | cellular ketone body metabolic process (GO:0046950) | 3.65464677 |
76 | drug transmembrane transport (GO:0006855) | 3.64994660 |
77 | tyrosine metabolic process (GO:0006570) | 3.61820623 |
78 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.60603598 |
79 | nephron tubule formation (GO:0072079) | 3.59783869 |
80 | cellular amino acid catabolic process (GO:0009063) | 3.54926858 |
81 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.52891546 |
82 | benzene-containing compound metabolic process (GO:0042537) | 3.52889586 |
83 | myoblast migration (GO:0051451) | 3.52346510 |
84 | negative regulation of lipase activity (GO:0060192) | 3.51448822 |
85 | cholesterol homeostasis (GO:0042632) | 3.50405645 |
86 | glandular epithelial cell differentiation (GO:0002067) | 3.50280415 |
87 | hemidesmosome assembly (GO:0031581) | 3.50187767 |
88 | regulation of cardioblast differentiation (GO:0051890) | 3.49395160 |
89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48769513 |
90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48769513 |
91 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.47392509 |
92 | sterol homeostasis (GO:0055092) | 3.46486318 |
93 | lipoprotein metabolic process (GO:0042157) | 3.45616382 |
94 | indolalkylamine metabolic process (GO:0006586) | 3.45424088 |
95 | plasma lipoprotein particle clearance (GO:0034381) | 3.43206937 |
96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42403624 |
97 | phospholipid homeostasis (GO:0055091) | 3.41657508 |
98 | chemical homeostasis within a tissue (GO:0048875) | 3.40936893 |
99 | thyroid hormone generation (GO:0006590) | 3.40753695 |
100 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.40363166 |
101 | surfactant homeostasis (GO:0043129) | 3.39949162 |
102 | drug metabolic process (GO:0017144) | 3.39860923 |
103 | ethanol metabolic process (GO:0006067) | 3.38419280 |
104 | serine family amino acid metabolic process (GO:0009069) | 3.37293194 |
105 | response to nitrosative stress (GO:0051409) | 3.36976678 |
106 | glutamate metabolic process (GO:0006536) | 3.36031044 |
107 | positive regulation of lipid catabolic process (GO:0050996) | 3.35745445 |
108 | short-chain fatty acid metabolic process (GO:0046459) | 3.35640638 |
109 | epoxygenase P450 pathway (GO:0019373) | 3.34064135 |
110 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.33014951 |
111 | glycine metabolic process (GO:0006544) | 3.32113723 |
112 | xenobiotic catabolic process (GO:0042178) | 3.31762962 |
113 | nodal signaling pathway (GO:0038092) | 3.30708795 |
114 | coenzyme catabolic process (GO:0009109) | 3.29186897 |
115 | protein-lipid complex assembly (GO:0065005) | 3.28283862 |
116 | exogenous drug catabolic process (GO:0042738) | 3.28121212 |
117 | vitamin transmembrane transport (GO:0035461) | 3.24914145 |
118 | fibrinolysis (GO:0042730) | 3.24337564 |
119 | carnitine metabolic process (GO:0009437) | 3.23280761 |
120 | carboxylic acid catabolic process (GO:0046395) | 3.22903753 |
121 | organic acid catabolic process (GO:0016054) | 3.22903753 |
122 | renal filtration (GO:0097205) | 3.20645547 |
123 | tight junction assembly (GO:0070830) | 3.20425576 |
124 | primary alcohol catabolic process (GO:0034310) | 3.20192174 |
125 | fatty acid oxidation (GO:0019395) | 3.19976768 |
126 | imidazole-containing compound metabolic process (GO:0052803) | 3.18224595 |
127 | segment specification (GO:0007379) | 3.18104801 |
128 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.17322151 |
129 | fatty acid beta-oxidation (GO:0006635) | 3.16868667 |
130 | glomerular filtration (GO:0003094) | 3.16511156 |
131 | thyroid hormone metabolic process (GO:0042403) | 3.13818618 |
132 | auditory receptor cell differentiation (GO:0042491) | 3.11582374 |
133 | peptide catabolic process (GO:0043171) | 3.11228829 |
134 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.05572900 |
135 | Golgi transport vesicle coating (GO:0048200) | 3.00724069 |
136 | COPI coating of Golgi vesicle (GO:0048205) | 3.00724069 |
137 | retinol metabolic process (GO:0042572) | 3.00655985 |
138 | amino-acid betaine transport (GO:0015838) | 2.92327490 |
139 | carnitine transport (GO:0015879) | 2.92327490 |
140 | face development (GO:0060324) | 2.91014606 |
141 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.89587612 |
142 | O-glycan processing (GO:0016266) | 2.86122225 |
143 | phenylpropanoid metabolic process (GO:0009698) | 2.83723194 |
144 | negative regulation of hormone metabolic process (GO:0032351) | 2.82175841 |
145 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.81902143 |
146 | endocrine pancreas development (GO:0031018) | 2.81048156 |
147 | generation of neurons (GO:0048699) | 2.80671235 |
148 | terpenoid biosynthetic process (GO:0016114) | 2.79863451 |
149 | sphingomyelin metabolic process (GO:0006684) | 2.78930216 |
150 | regulation of keratinocyte differentiation (GO:0045616) | 2.77877614 |
151 | primary alcohol metabolic process (GO:0034308) | 2.75424541 |
152 | maternal placenta development (GO:0001893) | 2.72484916 |
153 | COPII vesicle coating (GO:0048208) | 2.72308405 |
154 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.72224064 |
155 | ear development (GO:0043583) | 2.71076511 |
156 | regulation of transforming growth factor beta production (GO:0071634) | 2.68824120 |
157 | phosphate ion transmembrane transport (GO:0035435) | 2.68619278 |
158 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.68148857 |
159 | gap junction assembly (GO:0016264) | 2.67315293 |
160 | axonemal dynein complex assembly (GO:0070286) | 2.64695930 |
161 | regulation of cardioblast proliferation (GO:0003264) | 2.62176340 |
162 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.62176340 |
163 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.61178238 |
164 | epithelial cell maturation (GO:0002070) | 2.61145275 |
165 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.59924909 |
166 | digestion (GO:0007586) | 2.59903069 |
167 | negative regulation of catenin import into nucleus (GO:0035414) | 2.59473866 |
168 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.59225394 |
169 | artery smooth muscle contraction (GO:0014824) | 2.58509866 |
170 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.57952374 |
171 | embryonic eye morphogenesis (GO:0048048) | 2.55153963 |
172 | muscle cell migration (GO:0014812) | 2.54858143 |
173 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.54106277 |
174 | neuron fate specification (GO:0048665) | 2.53934031 |
175 | regulation of keratinocyte proliferation (GO:0010837) | 2.53691191 |
176 | negative regulation of complement activation (GO:0045916) | 2.53620509 |
177 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.53366108 |
178 | angiotensin maturation (GO:0002003) | 2.52508299 |
179 | quaternary ammonium group transport (GO:0015697) | 2.51055507 |
180 | steroid hormone mediated signaling pathway (GO:0043401) | 2.50527871 |
181 | carnitine transmembrane transport (GO:1902603) | 2.49714547 |
182 | transepithelial transport (GO:0070633) | 2.49234312 |
183 | sperm capacitation (GO:0048240) | 2.48200039 |
184 | thyroid gland development (GO:0030878) | 2.48198959 |
185 | negative regulation of cell fate commitment (GO:0010454) | 2.47279423 |
186 | ER overload response (GO:0006983) | 2.45898616 |
187 | mesenchyme morphogenesis (GO:0072132) | 2.45547689 |
188 | retinoic acid metabolic process (GO:0042573) | 2.44280971 |
189 | Leydig cell differentiation (GO:0033327) | 2.42775279 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.16396530 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.65575657 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.93922421 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.39853458 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.15915569 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.13814610 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.10362360 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.77680665 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.76838177 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.33287618 |
11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.85065921 |
12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.67774292 |
13 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.51431366 |
14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.34950717 |
15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.22526814 |
16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.12579309 |
17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.10598465 |
18 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.09542954 |
19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06613157 |
20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.02213869 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78254015 |
22 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.72244115 |
23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71539677 |
24 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.69879968 |
25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67149284 |
26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65788071 |
27 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.64103864 |
28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.63743098 |
29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57125118 |
30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55129990 |
31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46560796 |
32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43674722 |
33 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39150338 |
34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35932615 |
35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35413097 |
36 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.34417744 |
37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31076366 |
38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30067130 |
39 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25748159 |
40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24525690 |
41 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23637431 |
42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19023866 |
43 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.18608252 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14896593 |
45 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.13675637 |
46 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.12598280 |
47 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12200321 |
48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11687368 |
49 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.10507318 |
50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09802815 |
51 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.08131403 |
52 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.07640366 |
53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06173572 |
54 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.05934909 |
55 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.05934909 |
56 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.05934909 |
57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05244557 |
58 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02507637 |
59 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02091905 |
60 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01364832 |
61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99778920 |
62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99637791 |
63 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99627185 |
64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99030949 |
65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98147404 |
66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97701564 |
67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97583822 |
68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97050070 |
69 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94871804 |
70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92630322 |
71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90809756 |
72 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90738453 |
73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88515768 |
74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88366890 |
75 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.87949374 |
76 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87643155 |
77 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86333448 |
78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84574270 |
79 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82476332 |
80 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81901158 |
81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81860275 |
82 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.81516455 |
83 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81339864 |
84 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80495090 |
85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79498225 |
86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79498225 |
87 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78937394 |
88 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.78802885 |
89 | ATF3_27146783_Chip-Seq_COLON_Human | 0.77873088 |
90 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.76211470 |
91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75909753 |
92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75288732 |
93 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.73801794 |
94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.73682202 |
95 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.72748712 |
96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.72689072 |
97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71568246 |
98 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.70457033 |
99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.69836502 |
100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69403635 |
101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.69048962 |
102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.68682131 |
103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.68105430 |
104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.68105430 |
105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67950900 |
106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67536399 |
107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67536399 |
108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67076000 |
109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.66787796 |
110 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.65598525 |
111 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.65499483 |
112 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.65458868 |
113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65444801 |
114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65159916 |
115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.65116360 |
116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.64452637 |
117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.62504886 |
118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.61994400 |
119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.61445711 |
120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61152862 |
121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.58355572 |
122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.58036202 |
123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57668870 |
124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55747408 |
125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.55573742 |
126 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.55137359 |
127 | CJUN_26792858_Chip-Seq_BT549_Human | 0.54688764 |
128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54278477 |
129 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.54115414 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.68835946 |
2 | MP0005360_urolithiasis | 6.51970399 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.43520393 |
4 | MP0005365_abnormal_bile_salt | 5.22605802 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.43858426 |
6 | MP0001666_abnormal_nutrient_absorption | 3.72397734 |
7 | MP0003252_abnormal_bile_duct | 3.50397359 |
8 | MP0010234_abnormal_vibrissa_follicle | 3.42348322 |
9 | MP0003806_abnormal_nucleotide_metabolis | 3.18230638 |
10 | MP0010329_abnormal_lipoprotein_level | 2.91066924 |
11 | MP0005083_abnormal_biliary_tract | 2.67805770 |
12 | MP0003195_calcinosis | 2.62137693 |
13 | MP0009840_abnormal_foam_cell | 2.46404868 |
14 | MP0004019_abnormal_vitamin_homeostasis | 2.34454129 |
15 | MP0005332_abnormal_amino_acid | 2.27086145 |
16 | MP0004264_abnormal_extraembryonic_tissu | 2.20343009 |
17 | MP0003283_abnormal_digestive_organ | 2.11147082 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.97072517 |
19 | MP0002254_reproductive_system_inflammat | 1.85780929 |
20 | MP0002796_impaired_skin_barrier | 1.82719002 |
21 | MP0003191_abnormal_cellular_cholesterol | 1.82123448 |
22 | MP0005409_darkened_coat_color | 1.81934222 |
23 | MP0002909_abnormal_adrenal_gland | 1.79583485 |
24 | MP0003868_abnormal_feces_composition | 1.77710780 |
25 | MP0000609_abnormal_liver_physiology | 1.74756662 |
26 | MP0002118_abnormal_lipid_homeostasis | 1.74573397 |
27 | MP0010030_abnormal_orbit_morphology | 1.67591605 |
28 | MP0009643_abnormal_urine_homeostasis | 1.67158087 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.55162969 |
30 | MP0005451_abnormal_body_composition | 1.54695051 |
31 | MP0008004_abnormal_stomach_pH | 1.44481975 |
32 | MP0005220_abnormal_exocrine_pancreas | 1.41789145 |
33 | MP0005319_abnormal_enzyme/_coenzyme | 1.40795528 |
34 | MP0000762_abnormal_tongue_morphology | 1.30643207 |
35 | MP0004043_abnormal_pH_regulation | 1.29076606 |
36 | MP0002896_abnormal_bone_mineralization | 1.28200250 |
37 | MP0002098_abnormal_vibrissa_morphology | 1.25030408 |
38 | MP0005636_abnormal_mineral_homeostasis | 1.22585328 |
39 | MP0005503_abnormal_tendon_morphology | 1.17229633 |
40 | MP0010678_abnormal_skin_adnexa | 1.15931688 |
41 | MP0001188_hyperpigmentation | 1.15745800 |
42 | MP0004133_heterotaxia | 1.15252505 |
43 | MP0002163_abnormal_gland_morphology | 1.13073414 |
44 | MP0001764_abnormal_homeostasis | 1.12165816 |
45 | MP0002132_abnormal_respiratory_system | 1.09344403 |
46 | MP0005379_endocrine/exocrine_gland_phen | 1.05742751 |
47 | MP0003566_abnormal_cell_adhesion | 1.05645924 |
48 | MP0001756_abnormal_urination | 1.05258023 |
49 | MP0002060_abnormal_skin_morphology | 1.04172308 |
50 | MP0003453_abnormal_keratinocyte_physiol | 1.03649053 |
51 | MP0000579_abnormal_nail_morphology | 1.03092537 |
52 | MP0005408_hypopigmentation | 1.02292113 |
53 | MP0002233_abnormal_nose_morphology | 1.02171805 |
54 | MP0003866_abnormal_defecation | 1.01773807 |
55 | MP0000470_abnormal_stomach_morphology | 1.00863733 |
56 | MP0000462_abnormal_digestive_system | 1.00568898 |
57 | MP0000566_synostosis | 0.99037399 |
58 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98954482 |
59 | MP0003300_gastrointestinal_ulcer | 0.98597725 |
60 | MP0001270_distended_abdomen | 0.98062112 |
61 | MP0002876_abnormal_thyroid_physiology | 0.94961506 |
62 | MP0008789_abnormal_olfactory_epithelium | 0.93653411 |
63 | MP0005647_abnormal_sex_gland | 0.91462069 |
64 | MP0001765_abnormal_ion_homeostasis | 0.91378212 |
65 | MP0000538_abnormal_urinary_bladder | 0.90986878 |
66 | MP0003186_abnormal_redox_activity | 0.90248013 |
67 | MP0004782_abnormal_surfactant_physiolog | 0.89866795 |
68 | MP0002168_other_aberrant_phenotype | 0.89308097 |
69 | MP0005501_abnormal_skin_physiology | 0.89129274 |
70 | MP0003115_abnormal_respiratory_system | 0.87713016 |
71 | MP0005248_abnormal_Harderian_gland | 0.86635278 |
72 | MP0000003_abnormal_adipose_tissue | 0.85652625 |
73 | MP0003011_delayed_dark_adaptation | 0.85257033 |
74 | MP0009053_abnormal_anal_canal | 0.84702643 |
75 | MP0000681_abnormal_thyroid_gland | 0.83808437 |
76 | MP0000598_abnormal_liver_morphology | 0.83413174 |
77 | MP0009379_abnormal_foot_pigmentation | 0.81977674 |
78 | MP0001216_abnormal_epidermal_layer | 0.81917894 |
79 | MP0000627_abnormal_mammary_gland | 0.81661417 |
80 | MP0001873_stomach_inflammation | 0.81451075 |
81 | MP0000013_abnormal_adipose_tissue | 0.81054010 |
82 | MP0005084_abnormal_gallbladder_morpholo | 0.79322468 |
83 | MP0009384_cardiac_valve_regurgitation | 0.79303432 |
84 | MP0001485_abnormal_pinna_reflex | 0.76828480 |
85 | MP0000467_abnormal_esophagus_morphology | 0.75711918 |
86 | MP0001664_abnormal_digestion | 0.74714174 |
87 | MP0001177_atelectasis | 0.74405726 |
88 | MP0009642_abnormal_blood_homeostasis | 0.74136798 |
89 | MP0002396_abnormal_hematopoietic_system | 0.74000950 |
90 | MP0004381_abnormal_hair_follicle | 0.73974971 |
91 | MP0000377_abnormal_hair_follicle | 0.73264918 |
92 | MP0002078_abnormal_glucose_homeostasis | 0.73211886 |
93 | MP0002932_abnormal_joint_morphology | 0.72903029 |
94 | MP0000537_abnormal_urethra_morphology | 0.71858106 |
95 | MP0000613_abnormal_salivary_gland | 0.71788182 |
96 | MP0002136_abnormal_kidney_physiology | 0.71130230 |
97 | MP0000534_abnormal_ureter_morphology | 0.70592328 |
98 | MP0002089_abnormal_postnatal_growth/wei | 0.70207258 |
99 | MP0009697_abnormal_copulation | 0.69910695 |
100 | MP0009931_abnormal_skin_appearance | 0.69728388 |
101 | MP0005275_abnormal_skin_tensile | 0.68545113 |
102 | MP0005023_abnormal_wound_healing | 0.67402738 |
103 | MP0001944_abnormal_pancreas_morphology | 0.67326495 |
104 | MP0009764_decreased_sensitivity_to | 0.66013719 |
105 | MP0002877_abnormal_melanocyte_morpholog | 0.65616382 |
106 | MP0000383_abnormal_hair_follicle | 0.64999334 |
107 | MP0005381_digestive/alimentary_phenotyp | 0.64864387 |
108 | MP0001849_ear_inflammation | 0.63061006 |
109 | MP0004947_skin_inflammation | 0.62951724 |
110 | MP0001663_abnormal_digestive_system | 0.62635660 |
111 | MP0001346_abnormal_lacrimal_gland | 0.62600084 |
112 | MP0009780_abnormal_chondrocyte_physiolo | 0.60010047 |
113 | MP0000427_abnormal_hair_cycle | 0.58403633 |
114 | MP0010155_abnormal_intestine_physiology | 0.57367683 |
115 | MP0008469_abnormal_protein_level | 0.57119624 |
116 | MP0000477_abnormal_intestine_morphology | 0.56509792 |
117 | MP0003941_abnormal_skin_development | 0.56222627 |
118 | MP0003638_abnormal_response/metabolism_ | 0.55514555 |
119 | MP0009765_abnormal_xenobiotic_induced | 0.54640635 |
120 | MP0000604_amyloidosis | 0.54152605 |
121 | MP0009763_increased_sensitivity_to | 0.53999110 |
122 | MP0001881_abnormal_mammary_gland | 0.52726835 |
123 | MP0002277_abnormal_respiratory_mucosa | 0.52560738 |
124 | MP0003656_abnormal_erythrocyte_physiolo | 0.51783471 |
125 | MP0010386_abnormal_urinary_bladder | 0.51693190 |
126 | MP0010352_gastrointestinal_tract_polyps | 0.51420017 |
127 | MP0005187_abnormal_penis_morphology | 0.51151808 |
128 | MP0005448_abnormal_energy_balance | 0.50905466 |
129 | MP0003183_abnormal_peptide_metabolism | 0.50662087 |
130 | MP0000678_abnormal_parathyroid_gland | 0.49599082 |
131 | MP0010771_integument_phenotype | 0.49358863 |
132 | MP0002693_abnormal_pancreas_physiology | 0.48642777 |
133 | MP0003879_abnormal_hair_cell | 0.48111073 |
134 | MP0006054_spinal_hemorrhage | 0.47990243 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 6.56153956 |
2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.06618220 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.03793454 |
4 | Deep venous thrombosis (HP:0002625) | 5.58473102 |
5 | Lip pit (HP:0100267) | 5.38295216 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.36464540 |
7 | Xanthomatosis (HP:0000991) | 5.22498286 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 5.03873452 |
9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.36817509 |
10 | Fat malabsorption (HP:0002630) | 4.35330221 |
11 | Conjugated hyperbilirubinemia (HP:0002908) | 4.30382762 |
12 | Hypoglycemic coma (HP:0001325) | 4.17804771 |
13 | Decreased circulating renin level (HP:0003351) | 4.04977086 |
14 | Hypolipoproteinemia (HP:0010981) | 4.02734105 |
15 | Hyperammonemia (HP:0001987) | 4.00843262 |
16 | Hyperglycinuria (HP:0003108) | 3.98612135 |
17 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.93374621 |
18 | Complement deficiency (HP:0004431) | 3.88983259 |
19 | Hyperlipoproteinemia (HP:0010980) | 3.88694401 |
20 | Pili torti (HP:0003777) | 3.86895861 |
21 | Abnormality of renin-angiotensin system (HP:0000847) | 3.80816745 |
22 | Right ventricular cardiomyopathy (HP:0011663) | 3.79726465 |
23 | Ketosis (HP:0001946) | 3.79232087 |
24 | Hyperglycinemia (HP:0002154) | 3.76378193 |
25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.74478983 |
26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70319045 |
27 | Epidermoid cyst (HP:0200040) | 3.66910932 |
28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.56834323 |
29 | Abnormality of glycine metabolism (HP:0010895) | 3.56834323 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.56572078 |
31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.55223485 |
32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.51256401 |
33 | Malnutrition (HP:0004395) | 3.43084281 |
34 | Hypoalphalipoproteinemia (HP:0003233) | 3.41402988 |
35 | Hyperaldosteronism (HP:0000859) | 3.39314954 |
36 | Hyperphosphatemia (HP:0002905) | 3.38516071 |
37 | Joint hemorrhage (HP:0005261) | 3.37404675 |
38 | Ileus (HP:0002595) | 3.35283474 |
39 | Ketoacidosis (HP:0001993) | 3.30132333 |
40 | Rectal prolapse (HP:0002035) | 3.27064652 |
41 | Curly hair (HP:0002212) | 3.25173325 |
42 | Gout (HP:0001997) | 3.25083750 |
43 | Abnormality of purine metabolism (HP:0004352) | 3.11539969 |
44 | Abnormality of methionine metabolism (HP:0010901) | 3.08970052 |
45 | Hypoglycemic seizures (HP:0002173) | 3.05677092 |
46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05059344 |
47 | Chronic bronchitis (HP:0004469) | 3.04749637 |
48 | Steatorrhea (HP:0002570) | 3.04458131 |
49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.98674522 |
50 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.92098095 |
51 | Abnormal hair laboratory examination (HP:0003328) | 2.91815193 |
52 | Abnormal biliary tract morphology (HP:0012440) | 2.89576003 |
53 | Metabolic alkalosis (HP:0200114) | 2.87203989 |
54 | Hepatocellular carcinoma (HP:0001402) | 2.86477161 |
55 | Late onset (HP:0003584) | 2.86422529 |
56 | Abnormality of complement system (HP:0005339) | 2.82268864 |
57 | Hypercholesterolemia (HP:0003124) | 2.82196381 |
58 | Abnormal pancreas size (HP:0012094) | 2.80995666 |
59 | Hyperbilirubinemia (HP:0002904) | 2.80078860 |
60 | Septate vagina (HP:0001153) | 2.72784998 |
61 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.70847086 |
62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.68300515 |
63 | Vascular calcification (HP:0004934) | 2.66774485 |
64 | Abnormality of permanent molar morphology (HP:0011071) | 2.66261636 |
65 | Abnormality of the dental root (HP:0006486) | 2.66261636 |
66 | Taurodontia (HP:0000679) | 2.66261636 |
67 | Alopecia of scalp (HP:0002293) | 2.65990884 |
68 | Exocrine pancreatic insufficiency (HP:0001738) | 2.64536860 |
69 | Male infertility (HP:0003251) | 2.59448149 |
70 | Symptomatic seizures (HP:0011145) | 2.59380554 |
71 | Metabolic acidosis (HP:0001942) | 2.58551463 |
72 | Plantar hyperkeratosis (HP:0007556) | 2.57752211 |
73 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.52509395 |
74 | Abnormality of molar (HP:0011077) | 2.52204978 |
75 | Abnormality of molar morphology (HP:0011070) | 2.52204978 |
76 | Hyperactive renin-angiotensin system (HP:0000841) | 2.52069853 |
77 | Flat acetabular roof (HP:0003180) | 2.51293455 |
78 | Skin nodule (HP:0200036) | 2.50377368 |
79 | Increased circulating renin level (HP:0000848) | 2.50249058 |
80 | Abnormality of proline metabolism (HP:0010907) | 2.47185999 |
81 | Hydroxyprolinuria (HP:0003080) | 2.47185999 |
82 | Generalized aminoaciduria (HP:0002909) | 2.46840559 |
83 | Renal salt wasting (HP:0000127) | 2.46816651 |
84 | Acanthocytosis (HP:0001927) | 2.44826157 |
85 | Mitral stenosis (HP:0001718) | 2.44588506 |
86 | Alkalosis (HP:0001948) | 2.42670127 |
87 | Pancreatitis (HP:0001733) | 2.41741015 |
88 | Esophageal varix (HP:0002040) | 2.41391891 |
89 | Delayed CNS myelination (HP:0002188) | 2.39444296 |
90 | Hyperkalemia (HP:0002153) | 2.38827974 |
91 | Hyponatremia (HP:0002902) | 2.38720276 |
92 | Hypoplasia of dental enamel (HP:0006297) | 2.37569616 |
93 | Growth hormone excess (HP:0000845) | 2.36853066 |
94 | Hyperglycemia (HP:0003074) | 2.36513044 |
95 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.36329242 |
96 | Biliary tract neoplasm (HP:0100574) | 2.35832319 |
97 | Cardiovascular calcification (HP:0011915) | 2.34499409 |
98 | Abnormality of the dental pulp (HP:0006479) | 2.33772526 |
99 | Abdominal distention (HP:0003270) | 2.33465034 |
100 | Bronchiectasis (HP:0002110) | 2.32914372 |
101 | Hyperparathyroidism (HP:0000843) | 2.32438572 |
102 | Rhinitis (HP:0012384) | 2.31069209 |
103 | Hypotension (HP:0002615) | 2.30621556 |
104 | Myocardial infarction (HP:0001658) | 2.29202465 |
105 | Dicarboxylic aciduria (HP:0003215) | 2.28317472 |
106 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28317472 |
107 | Lethargy (HP:0001254) | 2.28023935 |
108 | Arterial tortuosity (HP:0005116) | 2.25833123 |
109 | Adrenal overactivity (HP:0002717) | 2.24170591 |
110 | Amelogenesis imperfecta (HP:0000705) | 2.23870319 |
111 | Proximal tubulopathy (HP:0000114) | 2.22565528 |
112 | Abnormality of nail color (HP:0100643) | 2.21489949 |
113 | Glycosuria (HP:0003076) | 2.20914074 |
114 | Abnormality of urine glucose concentration (HP:0011016) | 2.20914074 |
115 | Palmoplantar hyperkeratosis (HP:0000972) | 2.20893470 |
116 | Abnormality of potassium homeostasis (HP:0011042) | 2.20020443 |
117 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.19903413 |
118 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.19903413 |
119 | Hypokalemia (HP:0002900) | 2.19380325 |
120 | Irritability (HP:0000737) | 2.19134677 |
121 | Goiter (HP:0000853) | 2.18648090 |
122 | Abnormality of serum amino acid levels (HP:0003112) | 2.18315780 |
123 | Widely patent fontanelles and sutures (HP:0004492) | 2.15128111 |
124 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.15081725 |
125 | Rickets (HP:0002748) | 2.14029513 |
126 | Hyperuricemia (HP:0002149) | 2.13852887 |
127 | Increased purine levels (HP:0004368) | 2.13852887 |
128 | Hypoplastic labia majora (HP:0000059) | 2.13570637 |
129 | Abnormality of the gastric mucosa (HP:0004295) | 2.13489617 |
130 | Spontaneous abortion (HP:0005268) | 2.12160576 |
131 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.11726763 |
132 | Flattened epiphyses (HP:0003071) | 2.10789812 |
133 | Abnormality of chloride homeostasis (HP:0011422) | 2.10507080 |
134 | Atrophic scars (HP:0001075) | 2.10122914 |
135 | Breast carcinoma (HP:0003002) | 2.06176628 |
136 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.05744064 |
137 | Protuberant abdomen (HP:0001538) | 2.05533369 |
138 | Popliteal pterygium (HP:0009756) | 2.04858411 |
139 | Renal tubular acidosis (HP:0001947) | 2.03177995 |
140 | Abnormal ciliary motility (HP:0012262) | 2.02569054 |
141 | Spastic diplegia (HP:0001264) | 2.02498528 |
142 | Germ cell neoplasia (HP:0100728) | 2.02002527 |
143 | Abnormal cartilage morphology (HP:0002763) | 2.01786196 |
144 | Abnormality of vitamin metabolism (HP:0100508) | 2.01286579 |
145 | Atrioventricular block (HP:0001678) | 2.01212034 |
146 | Tongue fasciculations (HP:0001308) | 2.00574066 |
147 | Milia (HP:0001056) | 2.00547008 |
148 | Fragile nails (HP:0001808) | 1.99737629 |
149 | Palmar hyperkeratosis (HP:0010765) | 1.97774607 |
150 | Renal cortical cysts (HP:0000803) | 1.97562910 |
151 | Onycholysis (HP:0001806) | 1.96891873 |
152 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94412234 |
153 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.93811046 |
154 | Villous atrophy (HP:0011473) | 1.93811046 |
155 | Potter facies (HP:0002009) | 1.93591983 |
156 | Facial shape deformation (HP:0011334) | 1.93591983 |
157 | Abnormality of the nasal septum (HP:0000419) | 1.91791024 |
158 | Enlarged kidneys (HP:0000105) | 1.89450301 |
159 | Vomiting (HP:0002013) | 1.88232562 |
160 | Abnormality of vitamin B metabolism (HP:0004340) | 1.87319864 |
161 | Amyloidosis (HP:0011034) | 1.86839228 |
162 | Hypotrichosis (HP:0001006) | 1.86677618 |
163 | Abnormality of sodium homeostasis (HP:0010931) | 1.85854974 |
164 | Nausea (HP:0002018) | 1.85169054 |
165 | Nephrolithiasis (HP:0000787) | 1.83589298 |
166 | Abnormal hemoglobin (HP:0011902) | 1.82809507 |
167 | Abnormal gallbladder morphology (HP:0012437) | 1.82162017 |
168 | Abnormal tarsal ossification (HP:0008369) | 1.80351435 |
169 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77211680 |
170 | Systemic lupus erythematosus (HP:0002725) | 1.76599428 |
171 | Menorrhagia (HP:0000132) | 1.76378240 |
172 | Dehydration (HP:0001944) | 1.76178245 |
173 | Glomerulonephritis (HP:0000099) | 1.75412702 |
174 | Hypophosphatemic rickets (HP:0004912) | 1.75388610 |
175 | Neonatal onset (HP:0003623) | 1.75274656 |
176 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72404131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.31427056 |
2 | FRK | 4.07728172 |
3 | ERN1 | 3.74957979 |
4 | MST1R | 3.62035238 |
5 | LATS1 | 2.88826366 |
6 | SIK1 | 2.73612796 |
7 | FGFR4 | 2.68810139 |
8 | INSRR | 2.63039387 |
9 | TAOK3 | 2.58246854 |
10 | TRIB3 | 2.55321806 |
11 | EPHA2 | 2.51114893 |
12 | MAP3K2 | 2.40747135 |
13 | MST4 | 2.34291265 |
14 | LMTK2 | 2.17689529 |
15 | PTK6 | 2.06841949 |
16 | MAP3K3 | 2.02332835 |
17 | PASK | 1.99785239 |
18 | MAP2K2 | 1.99460325 |
19 | PKN2 | 1.95363864 |
20 | ERBB3 | 1.89567217 |
21 | IRAK3 | 1.86018464 |
22 | STK24 | 1.84949178 |
23 | ERBB4 | 1.82918804 |
24 | FER | 1.72291277 |
25 | MAP3K12 | 1.70214961 |
26 | MET | 1.56898968 |
27 | MAPK15 | 1.51887772 |
28 | STK38L | 1.50526264 |
29 | IRAK4 | 1.44038321 |
30 | SMG1 | 1.43090042 |
31 | EPHA3 | 1.41621270 |
32 | ACVR1B | 1.36977943 |
33 | RIPK1 | 1.35570712 |
34 | PIK3CG | 1.30433161 |
35 | FLT3 | 1.28375196 |
36 | PTK2 | 1.25892537 |
37 | MKNK2 | 1.19611598 |
38 | WNK4 | 1.16223612 |
39 | ERBB2 | 1.15902162 |
40 | EPHB1 | 1.14054165 |
41 | MAP3K10 | 1.05644555 |
42 | EPHB2 | 1.04088016 |
43 | AKT3 | 1.03038521 |
44 | MAPKAPK3 | 1.02411753 |
45 | PAK4 | 0.99605750 |
46 | DYRK1B | 0.98797289 |
47 | MAPK11 | 0.96651797 |
48 | STK39 | 0.96504602 |
49 | MAP2K6 | 0.92666216 |
50 | PIK3CA | 0.91331359 |
51 | OXSR1 | 0.91025196 |
52 | MAP2K1 | 0.90648548 |
53 | PRKG2 | 0.90544953 |
54 | NEK6 | 0.85746136 |
55 | CDK12 | 0.84181619 |
56 | DDR2 | 0.83874871 |
57 | TAOK1 | 0.79704422 |
58 | CDK6 | 0.78650047 |
59 | TYK2 | 0.76098489 |
60 | PRKAA2 | 0.76043625 |
61 | GSK3A | 0.73739481 |
62 | JAK2 | 0.73075713 |
63 | GRK1 | 0.72424758 |
64 | MAP3K9 | 0.71938677 |
65 | YES1 | 0.71427340 |
66 | MAP3K7 | 0.69818414 |
67 | LRRK2 | 0.69772023 |
68 | PRKCI | 0.68931900 |
69 | SCYL2 | 0.68765851 |
70 | MAP3K1 | 0.67981499 |
71 | FGFR2 | 0.66997747 |
72 | NUAK1 | 0.66532821 |
73 | WNK3 | 0.65432349 |
74 | RPS6KB2 | 0.65245552 |
75 | NME1 | 0.62357812 |
76 | MYLK | 0.61263628 |
77 | GRK6 | 0.61148414 |
78 | STK3 | 0.60841282 |
79 | NEK9 | 0.60300347 |
80 | LATS2 | 0.58912783 |
81 | ABL2 | 0.55427684 |
82 | DMPK | 0.55230596 |
83 | TESK1 | 0.55133511 |
84 | PDGFRA | 0.51965807 |
85 | PRKAA1 | 0.50893670 |
86 | IRAK1 | 0.49382493 |
87 | PAK3 | 0.49370435 |
88 | FGFR1 | 0.49087812 |
89 | MELK | 0.47180695 |
90 | ILK | 0.46960361 |
91 | STK10 | 0.46758472 |
92 | PDGFRB | 0.46525881 |
93 | MAP3K14 | 0.46152311 |
94 | TBK1 | 0.45982323 |
95 | MUSK | 0.45870044 |
96 | CAMK2D | 0.45276589 |
97 | PRKCE | 0.45103831 |
98 | DAPK2 | 0.44893350 |
99 | NTRK1 | 0.42329452 |
100 | CAMK2G | 0.41488215 |
101 | FGFR3 | 0.41405953 |
102 | NLK | 0.37895120 |
103 | TRPM7 | 0.37451287 |
104 | PDPK1 | 0.36287901 |
105 | BMPR2 | 0.36158342 |
106 | WNK1 | 0.36090198 |
107 | ROCK1 | 0.35775392 |
108 | RET | 0.35511661 |
109 | JAK1 | 0.34990225 |
110 | TGFBR2 | 0.34400705 |
111 | MAP2K4 | 0.34305676 |
112 | PRKCZ | 0.33380810 |
113 | MTOR | 0.33290164 |
114 | PRKD2 | 0.33281277 |
115 | EIF2AK1 | 0.33101393 |
116 | PDK2 | 0.32572558 |
117 | RPS6KA2 | 0.32397534 |
118 | PRKACG | 0.32337098 |
119 | CHUK | 0.32165713 |
120 | IGF1R | 0.28187525 |
121 | CDK8 | 0.27876231 |
122 | BMPR1B | 0.27872457 |
123 | KSR2 | 0.26161170 |
124 | HIPK2 | 0.25440886 |
125 | CASK | 0.24684141 |
126 | STK38 | 0.24591534 |
127 | SGK3 | 0.24587385 |
128 | EEF2K | 0.24515884 |
129 | PBK | 0.24024562 |
130 | MAP3K11 | 0.23837847 |
131 | PDK4 | 0.23710640 |
132 | PDK3 | 0.23710640 |
133 | RPS6KB1 | 0.22798931 |
134 | EIF2AK3 | 0.21390506 |
135 | MAPKAPK2 | 0.21171632 |
136 | MKNK1 | 0.20419030 |
137 | TGFBR1 | 0.20270703 |
138 | CDK9 | 0.19403993 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.60479845 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49213287 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02007569 |
4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63029821 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51659228 |
6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49660728 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49149901 |
8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.48247603 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.39589268 |
10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.39375253 |
11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.38170990 |
12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.34560789 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34388549 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22782758 |
15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.22659941 |
16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.15715585 |
17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.12167069 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.08633616 |
19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06276524 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.04628487 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.92794541 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91074845 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.81255273 |
24 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74212346 |
25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73771844 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70978027 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69047670 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67635246 |
29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.65024565 |
30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62295669 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.60642991 |
32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57013218 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55637595 |
34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52105582 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49874637 |
36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45858702 |
37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43554454 |
38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35596820 |
39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.35144800 |
40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27894128 |
41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26773241 |
42 | ABC transporters_Homo sapiens_hsa02010 | 1.25329556 |
43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20629427 |
44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19548584 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17527815 |
46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11762367 |
47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10718144 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05884395 |
49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05321746 |
50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03577583 |
51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02540989 |
52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02347199 |
53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98724003 |
54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98500701 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95793120 |
56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95020477 |
57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92979743 |
58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92922941 |
59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90887112 |
60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90291812 |
61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83896963 |
62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82254684 |
63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81062838 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.80432499 |
65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73838432 |
66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72366790 |
67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71501862 |
68 | Mineral absorption_Homo sapiens_hsa04978 | 0.70574643 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69584199 |
70 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68160964 |
71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68031148 |
72 | Adherens junction_Homo sapiens_hsa04520 | 0.67421473 |
73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66599571 |
74 | Insulin secretion_Homo sapiens_hsa04911 | 0.64358659 |
75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63449902 |
76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63306684 |
77 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63253159 |
78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62258618 |
79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60692439 |
80 | Renin secretion_Homo sapiens_hsa04924 | 0.60018035 |
81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59576423 |
82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57832479 |
83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52934056 |
84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52729427 |
85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51304808 |
86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50465234 |
87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50309374 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47974618 |
89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47887354 |
90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47719375 |
91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47493047 |
92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46563404 |
93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44783921 |
94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39840684 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.39662227 |
96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38560441 |
97 | Insulin resistance_Homo sapiens_hsa04931 | 0.37734303 |
98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34753784 |
99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34132000 |
100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33621480 |
101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33219370 |
102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33214162 |
103 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33071498 |
104 | Protein export_Homo sapiens_hsa03060 | 0.32195776 |
105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31768423 |
106 | Amoebiasis_Homo sapiens_hsa05146 | 0.31252392 |
107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30608006 |
108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.29661987 |
109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29212827 |
110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28961138 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28433047 |
112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26798744 |
113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25878626 |
114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23113378 |
115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.19622404 |
116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18269469 |
117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16105680 |
118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12193793 |
119 | Bladder cancer_Homo sapiens_hsa05219 | 0.11422251 |
120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09433508 |
121 | Hepatitis C_Homo sapiens_hsa05160 | 0.08260526 |
122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03977994 |
123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03899554 |
124 | Prion diseases_Homo sapiens_hsa05020 | 0.03145829 |
125 | Tight junction_Homo sapiens_hsa04530 | 0.02590007 |
126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00857874 |
127 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0296403 |
128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.0259003 |
129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0134660 |